“CDC’s new MMWR used data from the 2022 National Survey on Drug Use and Health (NSDUH) applied to a “cascade of care” framework to estimate and characterize U.S. adult populations who need OUD treatment, receive any OUD treatment, and receive medications for OUD.”
Publication Type: Government
Intended to be used with patients who are struggling with stimulant (cocaine/amphetamine) use while in treatment for OUD with methadone, buprenorphine, or naltrexone.